The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003.

During the past decade, Institute of Cancer Research - UK conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Cancer Research - UK" #1 sponsor was "Endocyte" with 1 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "ImCheck Therapeutics" with 1 trials sponsored, "Immunic AG" with 1 trials sponsored and "Institute of Cancer Research, United Kingdom" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Cancer Research - UK" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Cancer Research - UK" are "Brain Tumor" (1 trials), "Breast Cancer" (1 trials), "Glioma" (1 trials), "Hematopoietic/Lymphoid Cancer" (1 trials) and "Hot Flashes" (1 trials). Many other conditions were trialed in "Institute of Cancer Research - UK" in a lesser frequency.

Most popular intervention types in "Institute of Cancer Research - UK" are "Drug" (4 trials), "Biological" (3 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "177Lu-PSMA-617" (1 trials), "Best supportive/best standard of care" (1 trials), "IMU-935" (1 trials), "IV ICT01" (1 trials) and "Questionnaire" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Cancer Research - UK" are 5 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institute of Cancer Research - UK". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institute of Cancer Research - UK, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Cancer Research - UK, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Institute of Cancer Research - UK has several departments that took part in Clinical trials: "Institute of Cancer Research and Royal Marsden Hospital" - 17 trials, "Royal Marsden Hospital; Institute of Cancer Research" - 7 trials, "Institute of Cancer Research - Sutton" - 5 trials, "Royal Marsden Hospital - Institute of Cancer Research - Sutton" - 2 trials